Concepedia

Erick De La Torre Tarazona

ED

Statistics

Publications

6

Citations

470

H-Index

6

Active since

2019

Affiliations

Instituto de Salud Carlos III(Current)

Hospital Universitario La Paz

Centro Nacional de Microbiologia

Hospital Clínico San Carlos

Instituto de Investigación Sanitaria del Hospital Clínico San Carlos

Erick De La Torre Tarazona is an author at Instituto de Salud Carlos III specializing in medicine, immunology, and hiv.

ORCID

Top concepts

Publications per year

2019–2022

6

Publications

6

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

Alberto M. Borobia, Antonio J. Carcas, Mayte Pérez‐Olmeda et al. · The Lancet · 2021 · 384 citations · Full text

Elite controllers long-term non progressors present improved survival and slower disease progression

Laura Capa, Rubén Ayala-Suárez, Erick De La Torre Tarazona et al. · Scientific Reports · 2022 · 24 citations · Full text

Transcriptome Sequencing of Peripheral Blood Mononuclear Cells from Elite Controller-Long Term Non Progressors

Francisco Díez‐Fuertes, Erick De La Torre Tarazona, Esther Calonge et al. · Scientific Reports · 2019 · 17 citations · Full text

, , +21

Novel association of five HLA alleles with HIV-1 progression in Spanish long-term non progressor patients

Eva Ramírez de Arellano, Francisco Díez‐Fuertes, Francisco Aguilar et al. · PLoS ONE · 2019 · 16 citations · Full text

4-Deoxyphorbol inhibits HIV-1 infection in synergism with antiretroviral drugs and reactivates viral reservoirs through PKC/MEK activation synergizing with vorinostat

Erick De La Torre Tarazona, Rafael M. Mérida Jiménez, Pilar Rubio Bueno et al. · Biochemical Pharmacology · 2020 · 15 citations · Full text

, , +9

1–5 of 6